[Chemotherapy provides improved outcomes compared to novel hormonal therapy : Optimal treatment sequence after failure of abiraterone or enzalutamide]
Urologe A
.
2020 Apr 4.
doi: 10.1007/s00120-020-01177-x.
Online ahead of print.
[Article in German]
Author
Tilman Todenhöfer
1
2
Affiliations
1
Studienpraxis Urology, Clinical Trial Unit, Steinengrabenstr. 17, 72622, Nuertingen, Deutschland.
[email protected]
.
2
Medical School, University of Tuebingen, Tuebingen, Deutschland.
[email protected]
.
PMID:
32248275
DOI:
10.1007/s00120-020-01177-x
No abstract available